BioLine Rx Ltd (STU:YP2)
€ 2.7 +0.30 (+12.5%) Market Cap: 11.74 Mil Enterprise Value: 8.13 Mil PE Ratio: 9,999.00 PB Ratio: 0.79 GF Score: 26/100